| aGLP-1 | Active Glucagon-like Peptide-1 |
| ALT | Liver toxicity biomarker alanine transaminase |
| BMI | Body Mass Index |
| CFU | Colony Forming Units |
| CRP | C-Reactive Protein |
| CT | Clinical Trials |
| FMT | Fecal Microbiota Transplant |
| FPG | Fasting Plasma Glucose |
| GLP-1 | Glucagon-like peptide-1 |
| GLP-2 | Glucagon-like peptide-2 |
| HDL | High density lipoprotein |
| hsCRP | high sensitivity C-reactive protein |
| ISI | Index Sensitivity Insulin |
| LDL | Low density lipoprotein |
| NAFL | Non-Alcoholic Fatty Liver |
| NAFLD | Non-Alcoholic Fatty Liver Disease |
| NASH | Non-Alcoholic Steatohepatitis |
| NGP | Next-generation probiotics |
| OA | Open Access |
| PCR | Polymerase Chain Reaction |
| qPCR | quantitative Polymerase Chain Reaction |
| TAG | Triglycerides |
| VLDL | Very low-density lipoprotein |